Probi
PROB | ST
Overview
Corporate Details
- ISIN(s):
- SE0001280355
- LEI:
- 5493004CJOCT273MU397
- Country:
- Sweden
- Address:
- Ideongatan 1A, 223 70 Lund
- Website:
- https://www.probi.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Probi is an international company focused exclusively on developing, producing, and delivering clinically proven probiotics. We’ve spent three decades exploring and refining solutions that make the health-enhancing benefits of probiotics available to people everywhere. We are experts at managing stable, live bacteria from R&D through every stage of the manufacturing process, and into finished products, including bulk formats, supplements, and functional foods. Health concepts, formulations, and formats are supported by documentation. Since our founding at Sweden’s Lund University, in 1991, Probi has expanded its presence to more than 40 markets. We hold more than 400 patents globally.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-02-03 09:20 |
Regulatory News Service
Avnotering av Probi
|
Swedish | 99.1 KB | |
| 2025-02-03 09:20 |
Delisting Announcement
Delisting of Probi
|
English | 103.2 KB | |
| 2025-01-22 15:55 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 9.1 KB | |
| 2025-01-21 09:47 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 8.9 KB | |
| 2025-01-20 22:01 |
Takeover Announcement Report
Notice of Extraordinary General Meeting in Probi AB (publ)
|
English | 123.5 KB | |
| 2025-01-20 22:01 |
Declaration of Voting Results & Voting Rights Announcements
Kallelse till extra bolagsstämma i Probi AB (publ)
|
Swedish | 82.2 KB | |
| 2025-01-20 22:00 |
Delisting Announcement
Probi applies for delisting and convenes an Extraordinary General Meeting
|
English | 109.7 KB | |
| 2025-01-20 22:00 |
Regulatory News Service
Probi ansöker om avnotering och kallar till extra bolagsstämma
|
Swedish | 104.6 KB | |
| 2025-01-09 08:00 |
Regulatory News Service
Probi senarelägger bokslutskommuniké för 2024
|
Swedish | 92.1 KB | |
| 2025-01-09 08:00 |
Regulatory News Service
Probi postpones year-end report 2024
|
English | 81.1 KB | |
| 2024-12-13 17:18 |
Takeover Announcement Report
Statement from the independent bid committee of Probi in relation to the public…
|
English | 142.9 KB | |
| 2024-12-13 17:17 |
Takeover Announcement Report
Uttalande från den oberoende budkommittén i Probi med anledning av Symrise offe…
|
Swedish | 140.4 KB | |
| 2024-11-20 07:20 |
Takeover Announcement Report
Probi’s Board comments on Symrise’s public takeover offer
|
English | 101.9 KB | |
| 2024-11-20 07:19 |
Regulatory News Service
Probis styrelse kommenterar offentligt uppköpserbjudande från Symrise
|
Swedish | 104.9 KB | |
| 2024-07-16 08:00 |
Earnings Release
|
Swedish | 727.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-30 | Jean-Yves Parisot | Other | Buy | 142,586 | 49,905,100.00 SEK |
| 2024-11-22 | Jean-Yves Parisot | Other | Buy | 42,076 | 14,726,600.00 SEK |
| 2024-11-21 | Jean-Yves Parisot | Other | Buy | 77,405 | 27,091,750.00 SEK |
| 2024-11-20 | Jean-Yves Parisot | Other | Buy | 169,053 | 59,168,550.00 SEK |
| 2022-05-06 | Henrik Lundkvist | Other | Buy | 100 | 27,981.00 SEK |
| 2022-04-29 | Tom Rönnlund | Other | Buy | 400 | 122,296.00 SEK |
| 2022-04-28 | Tom Rönnlund | Other | Buy | 955 | 287,015.70 SEK |
| 2020-05-06 | Tom Rönnlund | Other | Buy | 400 | 100,000.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |